Axis Direct picks 5 smallcap stocks with up to 40% upside potential. How many do you have?

retained text

The Indian stock market has just set a record, but not one investors hoped for. Dalal Street has logged losses for eight consecutive weeks, surpassing the streaks seen during the 2020 Covid-19 crash and the 2008 global financial crisis. Axis has picked 5 smallcap stocks with strong value after the sharp correction.
Axis has assigned a target price of Rs 1,000, implying an upside of 19% from current market levels. It is a leading owner, developer, and asset manager of high-end hotels in India, primarily operating in key metro cities such as Mumbai, Hyderabad, Bengaluru, and Pune. The company’s portfolio includes luxury and upper-upscale hotels managed by renowned global brands like Marriott, Westin, and Four Points.
With a target price of Rs 820, the brokerage forecasts upside potential of 23% from current levels. The company has strategically positioned itself as India’s foremost pure-play oncology powerhouse, commanding a network of nearly 22 Comprehensive Cancer Centers (CCCs) and dedicated infusion facilities across the nation.
The company has a target price of Rs 815, an upside of 18% from the previous close. It is a major technology-driven manufacturer of automotive components and systems for both domestic and global original equipment manufacturers (OEMs). It is the flagship company of the Spark Minda Group and a leading supplier of mechatronic products, wiring harnesses, and vehicle access systems.
The brokerage has assigned a target price of Rs 280, an upside of about 24% from current levels. The bank has evolved from its regional roots into a pan-India franchise with 1,000+ branches, while retaining a strong presence in Tamil Nadu. CUB follows a granular, collateral-backed lending model, with MSMEs as its core focus, complemented by gold, agriculture, retail and other business loans.
With a target price of Rs 1,425, the brokerage forecasts 40% upside from current levels. It remains constructive on CCL Products' long-term growth prospects, supported by strong customer demand, a healthy order pipeline, new client additions, expanding branded sales and ongoing capacity expansion. Disclaimer: This article has been written by Veer Sharma, who is not a SEBI-registered Research Analyst or an Investment Adviser. Veer Sharma and his ‘relative(s)’ (as defined under Section 2(77) of the Companies Act, 2013) do not hold any financial interest in the companies mentioned in this article as of the date of publication. The views/recommendations mentioned in this article, wherever applicable, are those of the respective SEBI-registered Research Analyst/brokerage and have been reproduced/reported with due attribution. They should not be construed as the views or recommendations of The Economic Times Digital or the journalist. Readers are advised to consider the original research report and make their investment decisions based on their own assessment. Brokerage disclaimers here.

document fetched 2026-10-05 02:56